首页> 外文会议>PMSE Symposia >Preparation and Controlled Release of Chitosan Nanoparticles Loading Ginsenoside Rg1
【24h】

Preparation and Controlled Release of Chitosan Nanoparticles Loading Ginsenoside Rg1

机译:壳聚糖纳米粒子加载人参皂苷RG1的制备及控释释放

获取原文

摘要

Nanoparticles have been widely investigated as a carrier for drug delivery. Nanoparticles are good candidates for drug carrier to deliver drugs, because they are expected to be adsorbed in an intact form in the gastrointestinal tract after oral administration1. Chitosan with excellent biodegradable and biocompatible characteristics, is a naturally occurring polysaccharide. Chitosan has been examined extensively in the pharmaceutical industry for its potentialin the development of drug delivery systems2-3, because of its mucoadhesivity and ability to enhance the penetration of drugs across mucosal surface. Tripolyphosphate (TPP) is a polyanion, and can interact with cationic chitosan by electrostatic forces4. In Chinese traditional medicine research area, human have special interest in research nanoparticles based on chitosan-TPP crosslinking. Ginsenoside Rg1 was distilled from a kind of Chinese traditional medicine named KANG'AISAN. The aim of this study was to prepare Ginsenoside Rg1 nanoparticles based on different concentration of chitosan and TPP, to investigate their encapsulation efficiency, and to provide basic data for Ginsenoside Rg1 release from nanoparticles.
机译:已被广泛研究纳米粒子作为药物递送的载体。纳米粒子是用于递送药物的药物载体的良好候选者,因为预计它们在口服给药1后以胃肠道的完整形式吸附。壳聚糖具有优异的可生物降解和生物相容性特性,是一种天然存在的多糖。壳聚糖已经在制药行业中进行了广泛的研究,因为它占据了药物递送系统2-3的发展,因为它的粘接性和能力在粘膜表面上增强药物的渗透。三聚磷酸盐(TPP)是多沉变,可以通过静电力与阳离子壳聚糖与阳离子壳聚物相互作用。在中国传统医学研究领域,人类对基于壳聚糖交联的研究纳米粒子具有特殊兴趣。从一个名为kang'aisan的中国传统医学中蒸馏人参皂苷Rg1。本研究的目的是基于不同浓度的壳聚糖和TPP制备人参皂苷RG1纳米颗粒,以研究它们的包封效率,并为从纳米颗粒中的人参皂甙RG1释放提供基本数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号